Nervous Disorder TRIZ Cases

Autologous cord blood modulates neuroinflammation to address core autism symptoms, reducing reliance on symptomatic psychotropic medications.

IL-12 cytokine induces erythropoietin production to protect tissues from radiation-induced damage while maintaining tumor control during cancer therapy.

Targeted integration of antibody transgenes into safe harbor loci enables stable expression in secretory tissues.

Combining EGF and GHRP6 restores brain damage by suppressing galectin-3, overcoming narrow therapeutic windows.

Antibodies targeting ActRIIB inhibit signaling to promote muscle and bone growth despite limited prior efficacy.

A biomarker detection system measures cortisol and CRH levels to assess prophylactic treatment effectiveness.

Monitoring PHGDH expression levels enables targeted administration of NMDA receptor antagonists or inhibitors to manage neuronal disorders.

Non-naturally occurring peptides stimulate cholesterol efflux by binding to and stabilizing the ABCA1 transporter.

Ultrasonic processing of purified monomers in an organic phase creates consistent microspheres for reliable vascular occlusion.

Differentiating blood cell-derived iPSCs into midbrain neurons using sequential growth factor stages.

Combines C1-Inhibitor with immunoglobulin to scavenge complement fragments and modulate inflammation in cerebral ischemia treatment.

Combining anti-CD38 antibodies with lenalidomide triggers apoptosis, ADCC, and CDC to kill CD38+ cells.

Pre-freezing neonatal stromal cells at -70°C to -140°C enables long-term storage at -10°C to -40°C without specialized equipment.

Replacing disulfide bridges with thiazolidinone links reduces redox susceptibility while maintaining structural integrity in lantipeptides.

Conjugating a folate receptor-binding ligand with an imaging agent resolves the trade-off between diagnostic accuracy and non-specific tissue binding.

Isolated conotoxin κ-CPTx-bt102 blocks potassium channels to treat arrhythmia while minimizing toxic side effects from chemical drugs.

Segmented therapeutic and low-volume plasma exchange with human albumin reduces patient discomfort while preventing cognitive decline.

Alpha-amino boronic acid derivatives target the immunoproteasome subunit LMP7 to reduce side effects from broad proteasome inhibition in autoimmune treatments.

IgG2 Fc mutants with specific amino acid mutations reduce affinity for Fc gamma receptors, minimizing cytotoxicity while maintaining stability.

A trifunctional compound uses a covalent warhead to anchor radionuclides at tumor sites for stable retention.

Synthetic arginine substituted peptides replicate active lactoferrin sequences to treat infections while reducing production complexity.

Novel culture conditions direct human pluripotent stem cells into midbrain dopamine neurons with high purity and functional engraftment capability.

AcCoA depleting agents modulate autophagy levels to treat diseases while avoiding maladaptive tissue remodeling.

Mu-opiate receptor peptide salts improve stability and solubility, resolving efficiency bottlenecks in therapeutic production.

Filamentous bacteriophage g3p protein binds amyloid fibers to facilitate disaggregation.

Segmented guide RNAs and Cas9 nucleases enable permanent FXN gene corrections without complex protein engineering.

Bispecific antibodies combine CD20 targeting with transferrin receptor binding to deliver therapeutic payloads across the blood-brain barrier.

Chimeric fusion polypeptides resolve detergent belt interference in cryo-EM by replacing flexible linkers with rigid di-proline motifs to boost resolution.

A chimeric enzyme synthesizes capped RNA in the cytoplasm to bypass nuclear silencing barriers.

Glucose dendrimers utilize GLUT3 transporters to cross the blood-brain barrier and accumulate in neurons, bypassing off-target toxicity.

Supercritical carbon dioxide extraction stabilizes combined Echinacea and Zingiber extracts, preventing inactive compound formation during analgesic treatment.

Specific weight ratios of ginseng, ginkgo leaf, and stigma croci lower side effects and improve treatment outcomes for vascular dementia.

ADNF polypeptides resolve insufficient neuroprotective efficacy in autism and Alzheimer's disease through universality principles.

A stable carbidopa arginine salt formulation enables continuous subcutaneous administration of dopa decarboxylase inhibitors.

A composition containing eicosanoyl-5-hydroxytryptamide inhibits acetylcholinesterase activity and increases brain-derived neurotrophic factor expression.

Injecting therapeutic agents into the epidural space enables efficient biological molecule delivery to nervous tissue.

Composite nucleic acid inhibitory molecules utilize hairpin structures and modified nucleotides to bind target microRNAs with high specificity.

Segmenting purification into ion exchange and hydroxyapatite chromatography resolves the contradiction between manufacturing simplicity and product purity.

Adjusting harvest pH to 3.0-3.5 inactivates viruses early, reducing contamination without adding complex downstream processing steps.

Antibody-mediated clearance removes pathological Lewy bodies, reducing neurodegeneration and cognitive impairment.

A chemical cocktail induces somatic cells to differentiate into glia-like cells that secrete neurotrophic factors.

Pediococcus pentosaceus strain CECT 8330 induces interleukin-10 production to reduce intestinal inflammation in infants.

The tetanus toxin carboxyl-terminal domain targets motor neurons to deliver therapeutic agents.

Oral cinnamaldehyde formulations increase nerve sensation through composite ingredient synergy.

Non-mucoadhesive orally disintegrating film mimics immediate release tablets to resolve bioavailability inconsistency.

Recombinant AAV vectors deliver NeuroD1 to convert reactive astrocytes into functional neurons.

Isolated Bifidobacterium adolescentis strains increase trans-epithelial electrical resistance and induce IL-10 secretion to strengthen the gut lining.

Oral small molecule inhibitors block growth hormone receptor signaling to reduce chemotherapy toxicity and delay tumor growth.